86 related articles for article (PubMed ID: 3129603)
1. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. b. Trials of development of recombinant vaccinia polyvaccines].
Yasuda A; Kojima A
Nihon Rinsho; 1987 Oct; 45(10):2342-8. PubMed ID: 3129603
[No Abstract] [Full Text] [Related]
2. [New technology of vaccine production--international prospect of the development. Method and theory of production of vaccines by genetic engineering. a. Vaccinia vector vaccine].
Hashizume S; Morita M; Takahashi F
Nihon Rinsho; 1987 Oct; 45(10):2333-41. PubMed ID: 3482288
[No Abstract] [Full Text] [Related]
3. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
Flexner C; Hügin A; Moss B
Nature; 1987 Nov 19-25; 330(6145):259-62. PubMed ID: 3118219
[TBL] [Abstract][Full Text] [Related]
4. [New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. a. Application of genetic engineering using Saccharomyces cerevisiae].
Sakamoto S
Nihon Rinsho; 1987 Oct; 45(10):2322-5. PubMed ID: 3329247
[No Abstract] [Full Text] [Related]
5. Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome.
Cottingham MG; Gilbert SC
J Virol Methods; 2010 Sep; 168(1-2):233-6. PubMed ID: 20417665
[TBL] [Abstract][Full Text] [Related]
6. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
Chelyapov NV; Antonova TP; Yanova NN; Chernos VI
Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735
[TBL] [Abstract][Full Text] [Related]
7. A new genetically engineered vaccine for animal growth promotion.
Xu WZ; Du NX; Li GD; Wang Y; Li ZP
Sci China B; 1994 Oct; 37(10):1234-41. PubMed ID: 7865123
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biological study of the vaccinia virus genome. IV. The late nonstructural 36K protein of vaccinia virus is vitally important].
Shchelkunov SN; Riazankina OI; Gashnikov PB; Totmenin AB; Chizhikov VE; Malygin EG
Mol Biol (Mosk); 1991; 25(2):396-404. PubMed ID: 1908941
[TBL] [Abstract][Full Text] [Related]
9. [New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. b. Genetic engineering method using animal cells].
Nakada S
Nihon Rinsho; 1987 Oct; 45(10):2326-32. PubMed ID: 2834577
[No Abstract] [Full Text] [Related]
10. [New technology of vaccine production--international prospect of the development. Synthetic peptide vaccines and protein engineering].
Aimoto S; Sakiyama F
Nihon Rinsho; 1987 Oct; 45(10):2349-54. PubMed ID: 3502349
[No Abstract] [Full Text] [Related]
11. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase].
Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D
Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422
[No Abstract] [Full Text] [Related]
12. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters].
Loparev VN; Chernos VI
Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696
[TBL] [Abstract][Full Text] [Related]
13. [Molecular biology of vaccinia virus and development of a new type of vaccine].
Shida H
Uirusu; 1986 Jun; 36(1):23-33. PubMed ID: 3535240
[No Abstract] [Full Text] [Related]
14. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.
Morita M; Suzuki K; Yasuda A; Kojima A; Sugimoto M; Watanabe K; Kobayashi H; Kajima K; Hashizume S
Vaccine; 1987 Mar; 5(1):65-70. PubMed ID: 3554809
[TBL] [Abstract][Full Text] [Related]
16. Immunisation of cattle with a recombinant togavirus-vaccinia virus strain.
Franke CA; Berry ES; Smith AW; Hruby DE
Res Vet Sci; 1985 Jul; 39(1):113-5. PubMed ID: 3862196
[TBL] [Abstract][Full Text] [Related]
17. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
Taylor J; Paoletti E
Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
[TBL] [Abstract][Full Text] [Related]
18. [The vaccinia virus as a vector for genetically engineered vaccines and the study of viral protein functions].
Vopr Virusol; 1986; 31(4):509-12. PubMed ID: 3464128
[No Abstract] [Full Text] [Related]
19. [A recombinant vaccinia virus expressing the middle preS2-S envelope protein of the hepatitis B virus. The induction of humoral and cellular immunity by the immunization of laboratory animals].
Beliaev AS; Dmitriev IP; Ignat'ev GM; Mizenko GA; Putintseva NI; Sabirov AN; Samukov VV; Semënova LN; Ammosov AD; Rukavishnikov MIu
Dokl Akad Nauk SSSR; 1990; 314(2):488-91. PubMed ID: 2265587
[No Abstract] [Full Text] [Related]
20. Recombinant vaccinia viruses as new live vaccines.
Smith GL; Mackett M; Moss B
Biotechnol Genet Eng Rev; 1984; 2():383-407. PubMed ID: 6100668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
